[
  "Robert Duggan is a serial entrepreneur who sold his biotech firm Pharmacyclics to AbbVie in 2015, netting $3.5 billion in pretax cash and stock.",
  "The success of Pharmacyclics' cancer drug Imbruvica made him a billionaire in 2013.  ",
  "Duggan, whose son died from brain cancer, became passionate about Pharmacyclic's cancer fighting drugs and first invested in 2004. ",
  "His enthusiasm for investing began four decades earlier in a corporate finance class he took at University of California at Santa Barbara.",
  "Duggan now sits on the board of Pulse Biosciences, of which he is the largest individual shareholder."
]